Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100Hz, 100G)
Authors not listed · 2017
Specific EMF frequencies can enhance chemotherapy effectiveness against aggressive brain cancers, revealing complex biological interactions beyond simple harm.
Plain English Summary
Researchers tested whether extremely low-frequency electromagnetic fields (100 Hz, 100 Gauss) could enhance the cancer-fighting effects of temozolomide, a chemotherapy drug used for aggressive brain tumors called glioblastoma. They found that combining EMF exposure with the drug significantly increased cancer cell death compared to using either treatment alone. This suggests EMF might help overcome drug resistance in one of the deadliest forms of brain cancer.
Why This Matters
This study reveals a fascinating paradox in EMF research. While we typically focus on EMF's potential health risks, this research demonstrates how specific frequencies and intensities might actually enhance medical treatments. The 100 Hz frequency used here falls within the extremely low-frequency range you encounter from power lines and household wiring, though at much higher intensities (100 Gauss versus typical residential exposures of 1-4 milligauss). What makes this particularly significant is the target: glioblastoma multiforme, which has a median survival of just 15 months and resists most treatments. The researchers found that EMF exposure increased reactive oxygen species and triggered programmed cell death pathways that the cancer drug alone couldn't fully activate. This doesn't mean living near power lines fights cancer, but it does suggest that our understanding of EMF biological effects is far more nuanced than simple harm versus safety. The key lies in frequency, intensity, duration, and biological context.
Exposure Information
Specific exposure levels were not quantified in this study.
Show BibTeX
@article{cytotoxicity_of_temozolomide_on_human_glioblastoma_cells_is_enhanced_by_the_concomitant_exposure_to_an_extremely_low_frequency_electromagnetic_field_100hz_100g_ce3950,
author = {Unknown},
title = {Cytotoxicity of temozolomide on human glioblastoma cells is enhanced by the concomitant exposure to an extremely low-frequency electromagnetic field (100Hz, 100G)},
year = {2017},
doi = {10.1016/j.biopha.2017.05.050},
}